These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6246680)

  • 21. Serum antibodies to papova viruses (BK and SV 40) in subjects from the area with Balkan endemic nephropathy.
    Stoian M; Hozoc M; Iosipenco M; Nastac E; Melencu M
    Virologie; 1983; 34(2):113-7. PubMed ID: 6308885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experience in detecting donors as sources of serum hepatitis infection].
    Starshov PD; Ianvareva NM; Saenko VM; Prudnikov LM; Kotov BP
    Probl Gematol Pereliv Krovi; 1974 Sep; 19(9):53-5. PubMed ID: 4617878
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibodies to SV40 in sera from humans and macaques.
    Minor P; Pipkin PA
    Dev Biol (Basel); 2006; 123():99-107; discussion 119-32. PubMed ID: 16566439
    [No Abstract]   [Full Text] [Related]  

  • 24. Association between the occurrence of antibodies to simian vacuolating virus 40 and bladder cancer in male smokers.
    Bravo MP; Del Rey-Calero J
    Neoplasma; 1988; 35(3):285-8. PubMed ID: 2841614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simian virus 40, poliovirus vaccines, and human cancer: research progress versus media and public interests.
    Butel JS
    Bull World Health Organ; 2000; 78(2):195-8. PubMed ID: 10743284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution.
    Pancaldi C; Balatti V; Guaschino R; Vaniglia F; Corallini A; Martini F; Mutti L; Tognon M
    J Infect; 2009 Jan; 58(1):53-60. PubMed ID: 19070904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inability of antiserum active in antibody-dependent cellular cytotoxicity and arming tests to protect against simian virus 40 tumor cell challenge.
    Prather SO; Geller RW; Lausch RN
    J Natl Cancer Inst; 1979 May; 62(5):1273-7. PubMed ID: 220449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative determination of papovavirus IgG antibodies in sera from cancer patients, labworkers and several groups of control persons by enzyme-linked immunosorbent assay (ELISA).
    Zimmermann W; Scherneck S; Geissler E
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Apr; 254(2):187-96. PubMed ID: 6326419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospects for an SV40 vaccine.
    Imperiale MJ; Pass HI; Sanda MG
    Semin Cancer Biol; 2001 Feb; 11(1):81-5. PubMed ID: 11243902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction to simian virus 40: getting by with more than a little help from its host cell.
    Fanning E
    Dev Biol Stand; 1998; 94():3-8. PubMed ID: 9776219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of defective simian virus 40 genomes in establishment and maintenance of persistently infected primate cell lines.
    O'Neill FJ; Carroll D
    Intervirology; 1983; 19(4):181-94. PubMed ID: 6305869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum antibodies to some oncogenic viruses in the child.
    Arnaudova V; Nastac E; Predescu E
    Virologie; 1978; 29(4):245-9. PubMed ID: 219589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a role for SV40 in human cancer?
    Poulin DL; DeCaprio JA
    J Clin Oncol; 2006 Sep; 24(26):4356-65. PubMed ID: 16963733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SV40-positive brain tumor in scientist with risk of laboratory exposure to the virus.
    Arrington AS; Moore MS; Butel JS
    Oncogene; 2004 Mar; 23(12):2231-5. PubMed ID: 14676832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody response to simian virus 40 tumor antigen in nude mice reconstituted with T cells.
    Cicurel L; Croce CM
    J Immunol; 1977 Sep; 119(3):850-4. PubMed ID: 197168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sarcoma in a hamster inoculated with BK virus, a human papovavirus.
    Shah KV; Daniel RW; Strandberg JD
    J Natl Cancer Inst; 1975 Apr; 54(4):945-50. PubMed ID: 165302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SV40 infections in simians and humans.
    Shah KV
    Dev Biol Stand; 1998; 94():9-12. PubMed ID: 9776220
    [No Abstract]   [Full Text] [Related]  

  • 39. HTLV-I antibody screening in donated blood and thalassemic patients.
    Chiewsilp P; Iamsilp W; Hathirat P
    J Med Assoc Thai; 1993 Oct; 76 Suppl 2():103-5. PubMed ID: 7822977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of antibody response to simian virus 40 after inoculation with killed-poliovirus vaccine of mothers of offspring with neurologic tumors.
    Rosa FW; Sever JL; Madden DL
    N Engl J Med; 1988 Jun; 318(22):1469. PubMed ID: 2835679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.